Device / Technology News

RSS

Future of health care in practice at Cincinnati Children's Hospital Medical Center

The future of health care is here. And it's in practice at Cincinnati Children's.

7 Apr 2010

Payers, benefits administrators look for ways to reduce costs of managing benefits programs

Sending communications on healthcare benefits through the mail is an important channel in engaging members as they make benefits decisions and as program managers seek to influence member behavior, according to a study on Healthcare Benefit Communications Preferences by Pitney Bowes Management Services, Inc., a wholly owned subsidiary of Pitney Bowes Inc.

7 Apr 2010

Mobile compression device effective in preventing blood clots after hip replacement surgery

A mobile compression device is as effective as medication at preventing the formation of blood clots after hip replacement surgery but provides greater patient safety, according to a study in the March issue of the Journal of Bone & Joint Surgery.

7 Apr 2010

Kofax to provide large Australian insurance provider with document capture solution

Kofax plc, the leading provider of document driven business process automation solutions, today announced it will provide a document capture solution to one of Australia's largest insurance providers and leading workers compensation insurer. The value of the contract to Kofax is approximately $800,000.

7 Apr 2010

Implementation of electronic health record systems may not be enough to improve health quality

The implementation of electronic health record systems may not be enough to significantly improve health quality and reduce costs. In the April 2010 issue of Health Affairs, researchers from the Mongan Institute for Health Policy at Massachusetts General Hospital report finding that currently implemented systems have little effect on measures such as patient mortality, surgical complications, length of stay and costs.

7 Apr 2010

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

Sigma-Aldrich® announced today that it has signed an agreement with New Mexico Highlands University through its licensee, Highlands Stable Isotope Corp., to exclusively distribute a novel set of patented stable isotope labeled synthetic reagents.

7 Apr 2010

Tigermed Consulting signs alliance agreement with ICON

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries and Tigermed Consulting, a leader in the provision of clinical drug development services in China, today announced that they have signed an alliance agreement.

7 Apr 2010

IZI Medical Products introduces Mammography Indicator Markers

IZI Medical Products today announced that the company has developed and begun distributing two new lines of flat mammography markers, which are being manufactured in the United States and sold worldwide under the brand, Mammography Indicator® Markers.

7 Apr 2010

Guidant imposed criminal penalty over $296M for withholding cardioverter defibrillator failure information

Guidant LLC pleaded guilty today in St. Paul, Minn., before U.S. District Court Judge Donovan W. Frank to criminal violations of the Federal Food, Drug and Cosmetic Act, the Justice Department announced. The medical device manufacturer's admission of criminal wrongdoing is the result of a four-year investigation into Guidant's handling of short-circuiting failures of three models of its implantable cardioverter defibrillators: the Ventak Prizm 2 DR (Model 1861) and the Contak Renewal (Models H135 and H155).

7 Apr 2010

AbleNet adds Madentec's entire line of assistive technology solutions to product portfolio

AbleNet, Inc. announces the agreement with Madentec Limited of Edmonton, Alberta, Canada for the exclusive global rights to manufacture and sell their entire line of assistive technology solutions. This adds a broad portfolio of proven devices to the AbleNet computer access products. Madentec will continue to own the products and provide engineering development support, which has been their core strength.

7 Apr 2010

BD Diagnostics adds Innova Preanalytical Automated Microbiology Specimen Processor to product portfolio

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today the expansion of its product portfolio with the addition of the BD Innova™ Preanalytical Automated Microbiology Specimen Processor, which is designed to help increase laboratory efficiency and automate the modern microbiology laboratory.

From BD (Becton, Dickinson and Company) 7 Apr 2010

Rome Foundation develops Diagnostic Algorithms to diagnose GI symptoms

New clinical algorithms will give physicians a practical, efficient and cost-effective aid to diagnose the frequent gastrointestinal symptoms that patients commonly bring to their primary care doctors and gastroenterologists--symptoms of functional GI disorders that are often difficult to diagnose.

7 Apr 2010

SRU Biosystems extends product line with the introduction of BIND SCANNER

SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.

7 Apr 2010

FDA grants 510(k) clearance for STERIS SYSTEM 1E Liquid Chemical Sterilant Processing System

STERIS Corporation today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the STERIS SYSTEM 1E® Liquid Chemical Sterilant Processing System.

7 Apr 2010

Berwick, Blumenthal may form dream team at CMS

Healthcare IT News: "If Donald Berwick, MD, is confirmed as administrator of the Centers for Medicare and Medicaid Services, he and David Blumenthal, MD, the national coordinator for health IT, would be a 'dream team' in pursuing a coherent national healthcare and health IT strategy. At least that's the assessment of Kerry Weems, who spent 25 years in senior roles at the Health and Human Services Department and was acting administrator of CMS from Sept. 2007 until the Obama administration took over.

7 Apr 2010

IGRAs effective for detecting confirmed active TB disease: CHEST

New data from a meta-analysis of existing literature published today in CHEST, the official journal of the American College of Chest Physicians, demonstrate that Interferon Gamma Release Assays are superior to the previous standard in diagnostics, the 100+-year-old tuberculin skin test, for detecting confirmed active Tuberculosis disease.

7 Apr 2010

Accumetrics completes enrollment phase of GRAVITAS clinical trial

Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow® System, the first rapid and easy to use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced that it has completed the enrollment phase of its landmark clinical trial, GRAVITAS.

7 Apr 2010

New web-based technology platform for late phase clinical research

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has introduced a new web-based technology platform for late phase clinical research to meet the expanding regulatory and commercialization needs of the biopharmaceutical industry.

6 Apr 2010

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis. Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

6 Apr 2010

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.

6 Apr 2010

Device / Technology News

Future of health care in practice at Cincinnati Children's Hospital Medical Center

Payers, benefits administrators look for ways to reduce costs of managing benefits programs

Mobile compression device effective in preventing blood clots after hip replacement surgery

Kofax to provide large Australian insurance provider with document capture solution

Implementation of electronic health record systems may not be enough to improve health quality

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

Tigermed Consulting signs alliance agreement with ICON

IZI Medical Products introduces Mammography Indicator Markers

Guidant imposed criminal penalty over $296M for withholding cardioverter defibrillator failure information

AbleNet adds Madentec's entire line of assistive technology solutions to product portfolio

BD Diagnostics adds Innova Preanalytical Automated Microbiology Specimen Processor to product portfolio

Rome Foundation develops Diagnostic Algorithms to diagnose GI symptoms

SRU Biosystems extends product line with the introduction of BIND SCANNER

FDA grants 510(k) clearance for STERIS SYSTEM 1E Liquid Chemical Sterilant Processing System

Berwick, Blumenthal may form dream team at CMS

IGRAs effective for detecting confirmed active TB disease: CHEST

Accumetrics completes enrollment phase of GRAVITAS clinical trial

New web-based technology platform for late phase clinical research

New study shows utility of Chronix Biomedical's serum DNA tests in MS

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News